Acorda Therapeutics News
Most Popular Acorda Therapeutics Story
The best (and worst) biotech stocks of 2006
As we all know by now, pharma biotech investment is risky
at best and disasterous at worst. “No other sector produces as such huge gains or such steep losses in such short periods of time,” notes The Motley Fool’s Brian Lawler. Below is a year-end round-up of the five best and five worst performing biotech stocks.
Latest Headlines
- April 9, 2008
- July 25, 2007
- December 7, 2006
- December 1, 2006
- August 8, 2006
- March 14, 2006
- February 9, 2006
- October 5, 2005
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
